Emma Cahill
Overview
Explore the profile of Emma Cahill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeffrey J, Miller C, OSullivan J, Cahill E, Barrios A, Power D
Nurs Crit Care
. 2023 Aug;
28(5):789-799.
PMID: 37644907
Background: Peripheral nerve injuries (PNIs) can be acquired by patients in intensive care unit (ICU) who are critically unwell with Covid pneumonitis. Prone position ventilation has been linked to this...
2.
Pascoli V, Cahill E, Bellivier F, Caboche J, Vanhoutte P
Biol Psychiatry
. 2014 May;
76(12):917-26.
PMID: 24844603
Addiction is a chronic and relapsing psychiatric disorder that is thought to occur in vulnerable individuals. Synaptic plasticity evoked by drugs of abuse in the so-called neuronal circuits of reward...
3.
Cahill E, Salery M, Vanhoutte P, Caboche J
Front Pharmacol
. 2014 Jan;
4:172.
PMID: 24409148
Despite their distinct targets, all addictive drugs commonly abused by humans evoke increases in dopamine (DA) concentration within the striatum. The main DA Guanine nucleotide binding protein couple receptors (GPCRs)...
4.
Roze E, Cahill E, Martin E, Bonnet C, Vanhoutte P, Betuing S, et al.
Front Neuroanat
. 2011 Oct;
5:55.
PMID: 22007160
Huntington's Disease (HD) is the most frequent neurodegenerative disease caused by an expansion of polyglutamines (CAG). The main clinical manifestations of HD are chorea, cognitive impairment, and psychiatric disorders. The...
5.
Larkin A, Fahey B, Gobbo O, Callaghan C, Cahill E, OMara S, et al.
Brain Res
. 2008 Feb;
1199:126-32.
PMID: 18272142
Several forms of hippocampal-dependent learning rely upon activation of the N-methyl-d-aspartate (NMDA) subtype of glutamate receptor. Here we have investigated the effects of administration of the NMDA receptor antagonist (+/-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic...